BioNTech (BNTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal ...

German vaccine manufacturer BioNTech is to sponsor Bundesliga side Mainz, the club announced on Friday. Mainz said the ...

Sales of Keytruda from Merck reached $25 billion last year thanks to its position as a standard first line of treatment for ...

These extra doses will bring more highly specialised work making these novel molecules to contract manufacturing ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

The company's best days as a top pandemic vaccine supplier might be over, but it still has enough potential to be compelling.

Jefferies upgraded BioNTech (BNTX) to Buy from Hold with a price target of $150, up from $96. Following Summit Therapeutics' ...

The UK has approved its second Covid-19 vaccine for emergency use: AZ/Oxford’s candidate. This is welcome news given how ...

Enhertu is forecast to retain its dominant market position in the ADC landscape and reach global sales of $11.2bn by 2030.

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

Drones are set to play a vital role in the clinical supply chain across sub-Saharan Africa. How are these new logistical ...